About Datar Genetics
Datar Genetics is a company based in Nashik (India) founded in 1992 by Rajan Datar.. Datar Genetics has raised $2.98 million across 1 funding round from investors including Alkemi Partners. Datar Genetics offers products and services including Liquid Biopsy Tests and Circulating Tumor Cells Analysis. Datar Genetics operates in a competitive market with competitors including Guardant Health, Natera, Foundation Medicine, ArcherDX and Prenetics, among others.
- Headquarter Nashik, India
- Founders Rajan Datar
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Datar Cancer Genetics
-
Annual Revenue
$9.45 M (USD)-16as on Mar 31, 2024
-
Net Profit
$-896.03 K (USD)-227as on Mar 31, 2024
-
EBITDA
$2.47 M (USD)-49as on Mar 31, 2024
-
Total Equity Funding
$2.98 M (USD)
in 1 rounds
-
Latest Funding Round
$2.98 M (USD), Angel Round
Aug 26, 2024
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Datar Genetics
Datar Genetics offers a comprehensive portfolio of products and services, including Liquid Biopsy Tests and Circulating Tumor Cells Analysis. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Non-invasive blood tests for early cancer detection and monitoring.
Tests evaluating tumor cells in blood for cancer progression tracking.
Unlock access to complete
Funding Insights of Datar Genetics
Datar Genetics has successfully raised a total of $2.98M through 1 strategic funding round. The most recent funding activity was a Angel Round round of $2.98 million completed in August 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Angel Round — $3.0M
-
First Round
First Round
(26 Aug 2024)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2024 | Amount | Angel Round - Datar Genetics | Valuation | Alkemi Growth Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Datar Genetics
Datar Genetics has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Alkemi Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment in early-stage healthcare companies for consumer well-being and growth.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Datar Genetics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Datar Genetics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Datar Genetics Comparisons
Competitors of Datar Genetics
Datar Genetics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Natera, Foundation Medicine, ArcherDX and Prenetics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Health risks are identified through online genetic and diagnostic testing.
|
|
| domain | founded_year | HQ Location |
Blood-based liquid biopsy tests for multiple cancer detection are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Datar Genetics
Frequently Asked Questions about Datar Genetics
When was Datar Genetics founded?
Datar Genetics was founded in 1992 and raised its 1st funding round 32 years after it was founded.
Where is Datar Genetics located?
Datar Genetics is headquartered in Nashik, India. It is registered at Nashik, Maharashtra, India.
Is Datar Genetics a funded company?
Datar Genetics is a funded company, having raised a total of $2.98M across 1 funding round to date. The company's 1st funding round was a Angel Round of $2.98M, raised on Aug 26, 2024.
What is the annual revenue of Datar Genetics?
Annual revenue of Datar Genetics is $9.45M as on Mar 31, 2024.
What does Datar Genetics do?
Datar Genetics was established in 1992 and is based in Nashik, India. Operations center on biotechnology for cancer diagnostics using liquid biopsy techniques. The product lineup consists of TruBlood for non-invasive malignancy detection, CellDx for tumor genome sequencing, Exacta for treatment personalization via tumor profiling, and ChemoScale for in-vitro evaluation of chemotherapy resistance. Focus remains on accessible, non-invasive testing in oncology.
Who are the top competitors of Datar Genetics?
Datar Genetics's top competitors include Guardant Health, Foundation Medicine and Natera.
What products or services does Datar Genetics offer?
Datar Genetics offers Liquid Biopsy Tests and Circulating Tumor Cells Analysis.
Who are Datar Genetics's investors?
Datar Genetics has 1 investor. Key investors include Alkemi Partners.
What is Datar Genetics's valuation?
The valuation of Datar Genetics is $77.53M as of Aug 2024.